Catalyst Pharmaceuticals, Inc.
CPRX
$31.16
$0.020.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.15% | 30.78% | 52.36% | 206.19% | 203.07% |
| Total Depreciation and Amortization | 1.01% | 0.26% | 0.89% | 3.43% | 5.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,871.26% | 140.16% | 101.72% | -95.70% | -99.69% |
| Change in Net Operating Assets | -305.72% | -296.98% | -220.98% | 513.81% | 260.10% |
| Cash from Operations | -22.29% | -12.98% | 4.49% | 39.76% | 63.91% |
| Capital Expenditure | 76.19% | 89.57% | 99.69% | 98.97% | 99.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.19% | 89.57% | 99.71% | 99.72% | 99.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.43% | -90.51% | -87.42% | -88.34% | -88.35% |
| Repurchase of Common Stock | -3,634.72% | -3,952.84% | -101.67% | -101.67% | -55.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 63.04% | 65.18% | 65.90% | 1.08% | 2.21% |
| Cash from Financing | -1,330.42% | -112.08% | -90.40% | -98.18% | -97.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.17% | -49.56% | -22.96% | 40.73% | 66.65% |